Gene Signal International SA

Gene signal demonstrates activity of topical aganirsen in models of retinal neovascular disease

Topical aganirsen shows efficacy equivalent to Lucentis in models of AMD and ischemic retinopathy, inhibiting neovascularization by blocking IRS-1. The study demonstrates a novel compound with excellent safety profile for treating retinal neovascular disease.